• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Saturday 12/15/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

LXG

  • 5:51 PM

    BEVERLY, Mass., May 29, 2018 (GLOBE NEWSWIRE) — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into an agreement with the Stanford University School of Medicine.  The agreement involves using a targeted sequencing technology developed in the laboratory of Dr. Hanlee Ji, a Stanford associate professor of medicine, in combination with LexaGene’s microfluidic instrument.  “LexaGene’s technology was originally designed for pathogen detection across very large markets – I’m

    Read more
  • 1:29 PM

    Global Health Ventures (PublicWire) — Global Health Ventures Inc. (OTCBB: GHLV), or the “Company”, is pleased to announce that it has engaged Clinical Investigations Ltd. of United Kingdom to design and carry out the human clinical trials for X-Excite in Europe under the European Regulatory Guidelines (EMEA). The study is designed to compare three doses of X-Excite with the current oral formulation of sildenafil citrate (Viagra(R)) in a randomized open labeled study. The focus of the study will be to

    Read more
  • 3:27 PM

    “We look forward to rapidly expanding our global distribution … to department and specialty stores throughout Central Europe, as well as entering into franchise agreements with partners across Central and Eastern Europe for our brands.”

    Read more
Public Wire Banner